It has been 12 yr since the publication of the last World Health Organization (WHO)
classification of tumours of the prostate and bladder. During this time, significant new …

Context Urothelial carcinoma can exhibit a wide range of variant morphologies. Many
variants present diagnostic challenges and carry clinical implications that inform prognosis …

Purpose: This multidisciplinary, evidence-based guideline for clinically non-metastatic
muscle-invasive bladder cancer focuses on the evaluation, treatment and surveillance of …

Bladder cancer is a complex disease associated with high morbidity and mortality rates if not
treated optimally. Awareness of haematuria as the major presenting symptom is paramount …

Background Urothelial carcinoma (UC) is the most common pathological type of bladder
cancer, a malignant tumor. However, an integrated multi-omics analysis of the Chinese UC …

CONTEXT: New guidelines of the International Consultation on Urological Diseases for the
treatment of muscle-invasive bladder cancer (MIBC) have recently been published …

In the past 10 years evidence for the clinical relevance of variant histology in urinary bladder
cancer has been increasing. This increase has resulted in new classifications of urothelial …

Context Variant histology of muscle-invasive (MIBC) and metastatic (mBC) bladder cancer
may define the cancer treatment modality and oncological outcomes. Objective To …

It is well established that invasive urothelial carcinoma, involving the urinary bladder and
renal pelvis, has marked propensity for divergent differentiation. In recent years, several …

Purpose High-grade T1 (HGT1) bladder cancer is the highest risk subtype of non–muscle-
invasive bladder cancer, with highly variable prognosis, poorly understood risk factors, and …